Klivira
Request demo

Streamlining Trodelvy Prior Authorization for Dermatology Practices

Navigating **Trodelvy prior authorization for dermatology** requires precision and an understanding of complex payer requirements, a challenge Klivira is built to simplify for high-volume specialty drugs.

Dermatology practices contend with a significant prior authorization burden, driven by biologics, specialty drugs, and complex procedures. For any high-volume prescription, such as Trodelvy, efficient PA management is critical to maintaining revenue cycle integrity and patient access. Klivira provides the automation and intelligence necessary to navigate these complexities.

The Unique Prior Authorization Landscape in Dermatology

Dermatology prior authorization is heavily concentrated in biologics for chronic conditions like psoriasis, psoriatic arthritis, and atopic dermatitis, as well as specialty topicals and procedures such as Mohs micrographic surgery. The high volume of these requests, coupled with evolving payer policies, demands a robust and adaptable PA process to ensure timely approvals and minimize denials.

Managing High-Volume Specialty Drug PAs within Dermatology

While Trodelvy represents a high-volume prior authorization target across commercial, Medicare Advantage, and Medicaid managed care plans, managing any such specialty drug within a dermatology practice requires a strategic approach. Klivira's platform is designed to integrate seamlessly, applying intelligent automation to the PA workflow for complex drugs, reducing manual effort, and enhancing submission accuracy.

Common Prior Authorization Triggers in Dermatology

  • Biologics for psoriasis, psoriatic arthritis, and atopic dermatitis (e.g., Dupixent, Cosentyx, Tremfya, Skyrizi)
  • Biologics for hidradenitis suppurativa
  • Mohs micrographic surgery for non-melanoma skin cancers
  • Advanced skin cancer treatments, including immunotherapies and targeted therapies
  • Phototherapy, particularly for home administration
  • Specific biopsy and excision codes beyond routine procedures

Documentation Precision for Dermatology Prior Authorizations

Successful prior authorization in dermatology hinges on meticulous documentation that adheres to established clinical guidelines, such as those from the AAD and NCCN. Payers frequently require specific clinical criteria, evidence of prior therapy trials, and disease severity scores. Klivira's solutions help ensure that all necessary information is captured and submitted accurately, aligning with payer policy requirements.

Key Documentation Requirements for Dermatology PAs

  • Diagnosis criteria and severity documentation (e.g., PASI, EASI, BSA scores)
  • Documentation of prior topical, phototherapy, or conventional systemic therapy trials
  • Pre-biologic screening results (e.g., TB, hepatitis)
  • Age-appropriate criteria for specific biologic indications
  • Conformance to Appropriate Use Criteria (AUC) for Mohs surgery
  • Site and tumor type specifics for Mohs and advanced skin cancer treatments

Klivira's Role in Streamlining Dermatology Prior Authorizations

Klivira's platform addresses the specific challenges of dermatology PA by offering guideline-aware step-therapy logic for biologics, AUC validation for Mohs surgery, and intelligent handling of periodic re-authorization workflows. Our system integrates with EMRs, connects to payer portals, and automates medical-vs-pharmacy benefit routing, enabling dermatology practices to manage high-volume PAs with greater efficiency and fewer denials.

Frequently asked questions

How does Klivira handle the periodic re-authorization common for chronic biologic treatments in dermatology?

Klivira's platform is designed to manage and automate periodic re-authorization cycles, which are typical for chronic biologic treatments in dermatology. It tracks re-authorization dates, initiates the process proactively, and ensures all updated documentation is gathered and submitted efficiently to avoid treatment interruptions.

Can Klivira integrate with our existing EMR system for dermatology PA submissions?

Yes, Klivira specializes in seamless integration with major EMR systems. This allows for automated data extraction, pre-population of PA forms, and direct submission from your EMR, significantly reducing manual data entry and improving workflow efficiency for dermatology practices.

What specific dermatology clinical guidelines does Klivira support for prior authorization?

Klivira's logic engine incorporates key clinical guidelines relevant to dermatology, including those from the American Academy of Dermatology (AAD) for conditions like psoriasis and atopic dermatitis, and NCCN guidelines for skin cancers. It also validates against Appropriate Use Criteria (AUC) for procedures such as Mohs surgery.

How does Klivira help with medical versus pharmacy benefit routing for dermatology drugs?

Klivira intelligently routes prior authorization requests based on whether a dermatology drug falls under the medical or pharmacy benefit. This is crucial for self-injected home medications versus clinic-administered infusions, ensuring the correct payer channel is utilized for faster processing and accurate billing.

Does Klivira assist with documenting disease severity scores like PASI or EASI for biologic PAs?

Klivira's platform facilitates the collection and submission of essential disease severity scores, such as PASI (Psoriasis Area and Severity Index), EASI (Eczema Area and Severity Index), and BSA (Body Surface Area). This ensures that critical clinical criteria required by payers for biologic prior authorizations are accurately documented and included in submissions.

Related coverage

Other trodelvy prior authorization by payer

Other trodelvy prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo